CuraGen AI exists to design disease-modifying small molecules for hard-to-treat diseases and disorders.

We accelerate target-to-lead discovery by fusing generative AI, reinforcement learning and the most contemporary ML model architectures with deep biology and structure-based validation — delivering better candidates faster and more efficiently. Selected programs are translated toward clinical development through CuraGen Neuro Therapeutics, our therapeutics-development affiliate focused on CNS and neuro-oncology opportunities.